Thursday, 20 July
OFFICIAL PRESS CONFERENCE
Scientific highlights
08:00 – 09:00 AEST
Format: Virtual
Registration: Register here
-
Sharon Lewin, Press conference chair and IAS President (Australia)
-
Huachun Zou, Sun Yat-sen University (China): Voluntary medical male circumcision and incident HIV acquisition among men who have sex with men: a randomized controlled trial
-
Mina Hosseinipour, University of North Carolina Chapel Hill (United States): Initial PrEP product choice: results from the HPTN 084 open-label extension
-
Ana Hoxha, World Health Organization (Switzerland): HIV among mpox cases: clinical characteristics and outcomes in the WHO global surveillance 2022
-
Meg Doherty, World Health Organization (Switzerland): High in-hospital mortality in SARS-CoV-2 infected patients living with HIV during pre-Delta, Delta and Omicron variant waves: finding from the WHO Global Clinical Platform for COVID-19
-
Asier Sáez-Cirión, Institut Pasteur (France) & Alexandra Calmy, Geneva Hospitals (Switzerland): Absence of viral rebound for 18 months without antiretrovirals after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells to treat a biphenotypic sarcoma
-
Gabriela Cromhout, University of KwaZulu-Natal (South Africa): Sustained aviraemia in the absence of anti-retroviral therapy in male children following in utero vertical HIV transmission
-
Phil Arandjelovic, The Walter and Eliza Hall Institute of Medical Research (Australia): Venetoclax, alone and in combination with the BH3-mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
Monday, 24 July
OFFICIAL PRESS CONFERENCE
HIV in Australia
09:00 – 10:00 AEST
Format: Hybrid
Registration: Register here
-
Charles Gilks, Press conference chair and IAS 2023 Local Co-Chair (Australia)
-
Andrew Grulich, Kirby Institute (Australia): New data on trends towards HIV elimination in New South Wales
-
Skye McGregor, Kirby Institute (Australia): Australia’s progress towards ending HIV as a public health threat: trends in epidemiological metrics over 2004-2021
-
Martin Holt, University of New South Wales (Australia): Increasing prevention coverage among Australian gay and bisexual men but elevated HIV risk among younger and bisexual men: analysis of national behavioural surveillance data 2017-21
-
Curtis Chan, Kirby Institute (Australia): Increased Use of Event-Driven PrEP During COVID-19 in Australia: Results From Behavioural Surveillance 2019-2021
-
Sharon Lewin, Peter Doherty Institute for Infection and Immunity (Australia): Molecular and phylodynamic approaches to the characterisation of HIV-1 transmission: A genomic epidemiological study in Victoria, Australia
-
Heather Ellis, Living Positive Victoria (Australia): Perspective of the needs of people living with HIV